Hypertension

This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics  and renal denervation therapy. 

An example of renal denervation therapy being delivered. A catheter is inserted into the renal artery to ablate the nerves in the vessel wall that regulate vasoconstriction. This leaves the vessel permanently in the widest open position to allow greater blood flow to the kidneys.

An example of renal denervation therapy being delivered. A catheter is inserted into the renal artery to ablate the nerves in the vessel wall that regulate vasoconstriction. This leaves the vessel permanently in the widest open position to allow greater blood flow to the kidneys.

Feature | Renal Denervation | May 30, 2018
May 30, 2018 — Despite the best efforts of clinicians to manage hypertension, it continues to increase and is now...
Renal Denervation Shows Significant Drop in Hypertension
News | Renal Denervation | May 23, 2018
May 23, 2018 – At the 2018 EuroPCR Annual Meeting in Paris, Medtronic announced first-ever-data from the SPYRAL HTN-ON...
Medtronic Announces Renal Denervation Pivotal Trial for Hypertension Treatment
News | Renal Denervation | April 16, 2018
April 16, 2018 — Medtronic plc announced U.S. Food and Drug Administration (FDA) approval to begin an investigational...
YMCA and American Heart Association Partner to Improve Blood Pressure Control
News | Hypertension | April 05, 2018
April 5, 2018 — YMCA of the USA (Y-USA) and the American Heart Association (AHA) are combining efforts to help more...
Higi Implementing New ACC/AHA Blood Pressure Guidelines at 11,000 North American Stations
News | Hypertension | March 28, 2018
March 28, 2018 — Population health enablement company Higi announced their commitment to implement the 2017 American...
A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American College...
Low-Dose ‘Triple Pill’ Lowers Blood Pressure More Than Usual Care
News | ACC | March 20, 2018
March 20, 2018 — A pill combining low doses of three blood pressure-lowering medications significantly increased the...
Managing Blood Pressure in Barbershops Yields Substantial Improvements

Image from presentation, "A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops," Victor et al

News | ACC | March 20, 2018
March 20, 2018 — African-American men who received medical intervention aimed at controlling their high blood pressure...
Petaluma Health Center Wins 2017 HIMSS Davies Award for Hypertension Control Program
News | Hypertension | February 16, 2018
February 16, 2018 — California’s Petaluma Health Center (PHC) was recently awarded a 2017 Healthcare Information and...
Women who develop high blood pressure during pregnancy are more likely to experience heart failure and heart attack. American Heart Association (AHA), #AHA2017
News | Womens Cardiovascular Health | December 06, 2017
December 6, 2017 — Women who develop high blood pressure during pregnancy are more likely to experience heart problems...
SPRINT Trial Data Support New AHA/ACC Hypertension Guidelines
News | Hypertension | November 16, 2017
November 16, 2017 — Findings from a landmark study funded by the National Institutes of Health (NIH) support a key...
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension | September 14, 2017
September 14, 2017 — Marijuana use is associated with a three-fold risk of death from hypertension, according to...
Text Messaging Could Help Tackle High Blood Pressure in At-Risk Patients

Image courtesy of Michigan Medicine

News | Hypertension | September 06, 2017
September 6, 2017 — A new National Institutes of Health-funded hypertension trial will examine the possibility of using...
SPYRAL HTN-OFF MED Study Results Show Efficacy, Safety of Renal Denervation
News | Renal Denervation | August 31, 2017
August 31, 2017 — Medtronic plc announced its intent to move forward with a new renal denervation pivotal trial...
MobiusHD Device Shows Promise in Treatment of Resistant Hypertension
News | Hypertension | August 30, 2017
August 30, 2017 — Vascular Dynamics Inc. announced interim results of the company’s first-in-human trial of its...